RSV vaccines | NITAG RESOURCE CENTER

Proportion of the population affected by the disease or infected with the antigen

By the age of 2 almost all children will have been infected with RSV, with approximately 1/4-1/3 developing lower respiratory tract disease; RSV infections recur throughout life but disease severity is lower in older children and healthy young adults, and begins to rise again among elderly persons (e.g., over 65 years of age). ^{Go to footnote 11, Go to footnote 22}

Sources

Go back to footnote reference 1
Glezen WP, Taber LH, Frank AL, Kasel JA (1986). Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 140:543–546. doi:10.1001/archpedi.1986.02140200053026.
Go back to footnote reference 2
Fleming JA, Baral R, Higgins D, Khan S, Kochar S, Li Y, et al. (2023). Value profile for respiratory syncytial virus vaccines and monoclonal antibodies. Vaccine. 41(Suppl 1):S7. doi:10.1016/j.vaccine.2022.09.081.